Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Fennec Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +13 vs. Q3 2022
- Shares held
- 12.5M
- +1.12M (+9.9%) vs. Q3 2022
- Total value
- $119.5M
- +$27.7M (+30.2%) vs. Q3 2022
- New holders
- 18
- 10 more added
- Sold out
- 5
- 7 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 90 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.9M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.7M |
| Q2 2024 | 64 | $87.8M |
| Q1 2024 | 65 | $162.9M |
| Q4 2023 | 56 | $169.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $50.5M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $114.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 4,077,214 | $39.1M | 1.01% | 00.0% | Unchanged |
| Sonic GP LLC | 2,407,357 | $23.1M | 17.34% | +2,407,357 | New |
| Solas Capital Management, LLC | 1,252,388 | $12.0M | 7.21% | +121,221+10.7% | Added |
| Avoro Capital Advisors LLC | 1,200,000 | $11.5M | 0.17% | 00.0% | Unchanged |
| DG Capital Management, LLC | 1,021,952 | $9.81M | 6.00% | +16,851+1.7% | Added |
| Harbert Fund Advisors, Inc. | 316,949 | $3.04M | 2.62% | +127,199+67.0% | Added |
| 683 Capital Management, LLC | 300,000 | $2.88M | 0.26% | −84,824−22.0% | Reduced |
| Opaleye Management Inc. | 272,200 | $2.61M | 0.91% | +272,200 | New |
| Tamarack Advisers, LP | 213,000 | $2.04M | 1.48% | +38,000+21.7% | Added |
| EAM Investors, LLC | 176,452 | $1.69M | 0.35% | −368−0.2% | Reduced |
| Gendell Jeffrey L | 153,070 | $1.47M | 0.13% | +153,070 | New |
| Millennium Management LLC | 127,289 | $1.22M | 0.00% | −122,048−48.9% | Reduced |
| Susquehanna International Group, LLP | 107,613 | $1.03M | 0.00% | +107,613 | New |
| CIBC World Markets Inc. | 99,363 | $954.0K | 0.00% | +99,363 | New |
| 1492 Capital Management LLC | 94,870 | $910.8K | 0.59% | +94,870 | New |
| Two Sigma Investments, LP | 87,671 | $841.6K | 0.00% | +87,671 | New |
| Apis Capital Advisors, LLC | 58,000 | $556.8K | 0.65% | +58,000 | New |
| Two Sigma Advisers, LP | 55,000 | $528.0K | 0.00% | +55,000 | New |
| Tamar Securities, LLC | 53,475 | $513.4K | 0.16% | 00.0% | Unchanged |
| BlackRock Inc. | 50,544 | $485.2K | 0.00% | +1,177+2.4% | Added |
| Morgan Stanley | 45,376 | $435.6K | 0.00% | +9,314+25.8% | Added |
| Hartford Financial Management Inc. | 39,848 | $382.5K | 0.10% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 34,200 | $328.3K | 0.01% | +34,200 | New |
| Citadel Advisors LLC | 28,054 | $269.3K | 0.00% | +12,378+79.0% | Added |
| Jane Street Group, LLC | 25,866 | $248.3K | 0.00% | +11,359+78.3% | Added |
| Jump Financial, LLC | 20,991 | $201.5K | 0.01% | +20,991 | New |
| Goldman Sachs Group Inc | 20,985 | $201.5K | 0.00% | +20,985 | New |
| Geode Capital Management, LLC | 19,507 | $187.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 17,272 | $165.8K | 0.00% | +17,272 | New |
| Citigroup Inc | 16,848 | $162.8K | 0.00% | +16,848 | New |
| Man Group plc | 13,630 | $130.8K | 0.00% | +13,630 | New |
| Ancora Advisors, LLC | 12,245 | $118.0K | 0.00% | +5,000+69.0% | Added |
| NewEdge Wealth, LLC | 10,000 | $96.0K | 0.00% | +10,000 | New |
| Barclays PLC | 9,260 | $88.9K | 0.00% | +9,260 | New |
| Advisor Group Holdings, Inc. | 3,892 | $37.0K | 0.00% | −7,218−65.0% | Reduced |
| Tower Research Capital LLC (TRC) | 3,092 | $29.0K | 0.00% | −519−14.4% | Reduced |
| Simplex Trading, LLC | 2,921 | $28.0K | 0.00% | +2,921 | New |
| Bank of America Corp | 2,200 | $21.1K | 0.00% | −420−16.0% | Reduced |
| Royal Bank of Canada | 291 | $3.00K | 0.00% | +277+1,978.6% | Added |
| BNP Paribas Arbitrage, SA | 170 | $1.63K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 112 | $1.07K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 70 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 64 | $614 | 0.00% | −3,035−97.9% | Reduced |
| Sonic Fund II, L.P. | 0 | $0 | 0.00% | −2,407,357−100.0% | Sold out |
| Valley Forge Investment Consultants Inc Adv | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −14,924−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |